Showing results (31-40 of 80) with videos related to
Sort By:
Pageof 8
International Journal of Cardiology|June 17, 2022
Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-headAlice Barinotti, Massimo Radin, Irene Cecchi, et al.Autoimmunity Reviews|September 16, 2018
Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targetsIrene Cecchi, Ivan Arias de la Rosa, Elisa Menegatti, et al.Frontiers in Medicine|February 18, 2021
Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective StudySavino Sciascia, Massimo Radin, Irene Cecchi, et al.Clinical and Experimental Rheumatology|October 28, 2022
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocolSavino Sciascia, Massimo Radin, Irene Cecchi, et al.Frontiers in Immunology|March 29, 2024
Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentationIrene Cecchi, Massimo Radin, Alice Barinotti, et al.Journal of Clinical Medicine|June 10, 2022
Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric ExperienceSavino Sciascia, Alice Barinotti, Massimo Radin, et al.Life (Basel, Switzerland)|May 4, 2026
Beyond the Usual Suspects: IgG4-Related Disease as a Rare Culprit in Cardiac Valvular DisordersPiera Costanzo, Savino Sciascia, Giacomo Quattrocchio, et al.European Journal of Internal Medicine|October 22, 2022
"How we treat" clinical dilemmas in antiphospholipid syndrome: A case-based approachIrene Cecchi, Massimo Radin, Silvia Grazietta Foddai, et al.International Journal of Molecular Sciences|November 26, 2022
Renal Fibrosis in Lupus NephritisSavino Sciascia, Martina Cozzi, Alice Barinotti, et al.Kidney Medicine|February 2, 2026
Caveolin-1 as a Marker of Endothelial Damage in Primary Antiphospholipid Syndrome NephropathySavino Sciascia, Massimo Radin, Irene Cecchi, et al.Pageof 8